Latest Revenue Growth News

Page 214 of 249
Locate Technologies Limited reported flat group revenue for Q3 FY25, with Locate2u growing 10% while Zoom2u declined 11%. The company continues to embed AI as a strategic growth and cost optimization tool.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Zoom2u Technologies reports steady group revenue with Locate2u growing 10%, supported by AI initiatives that cut staff costs and a $0.5 million capital raise.
Sophie Babbage
Sophie Babbage
30 Apr 2025
RooLife Group Ltd (RLG) has inked exclusive decade-long agreements with three Chinese companies to market and distribute branded solar energy systems worldwide, marking a strategic expansion into the renewable energy sector.
Victor Sage
Victor Sage
30 Apr 2025
Cluey’s Q3 FY25 results reveal a strong 24% surge in new student enrolments and a narrowing underlying EBITDA loss, signaling a pivotal step toward profitability and renewed revenue growth.
Victor Sage
Victor Sage
30 Apr 2025
Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Cluey Ltd reported a 24% surge in new student enrolments in Q3 FY25 alongside a 46% reduction in cash burn, signaling improved operational efficiency and a clearer path to profitability.
Victor Sage
Victor Sage
30 Apr 2025
Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.
Ada Torres
Ada Torres
30 Apr 2025
Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.
Victor Sage
Victor Sage
30 Apr 2025
Orthocell has secured Health Canada approval for its nerve repair product Remplir™, adding the US$75 million Canadian market and expanding its total addressable market to US$1.8 billion. The company plans to appoint local distributors and expects first sales in H2 2025.
Ada Torres
Ada Torres
30 Apr 2025
Gratifii Limited reported a record quarterly cash receipt surge of 111% year-on-year, driven by key contract wins and successful platform migration despite cyclone disruptions. The company advances its post-merger integration and eyes an $84m revenue run rate in FY26.
Sophie Babbage
Sophie Babbage
30 Apr 2025
archTIS has reported a standout March quarter with record annual recurring revenue, improved gross margins, and strategic growth through the Direktiv acquisition and new international contracts.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Appen Limited reported a 12% revenue increase excluding Google in Q1 FY25, alongside a significant improvement in underlying EBITDA and a robust cash position, setting a positive tone for the year ahead.
Sophie Babbage
Sophie Babbage
30 Apr 2025